Hoisington, Andrew J.
Stamper, Christopher E.
Bates, Katherine L.
Stanislawski, Maggie A.
Flux, Michael C.
Postolache, Teodor T.
Lowry, Christopher A.
Brenner, Lisa A.
Funding for this research was provided by:
U.S. Air Force Academy (FA7000-16-2-0013)
Article History
Received: 20 January 2023
Accepted: 18 April 2023
First Online: 20 April 2023
Competing interests
: Dr. Brenner reports Grants from the VA, DOD, NIH, and the State of Colorado, editorial renumeration from Wolters Kluwer, and royalties from the American Psychological Association and Oxford University Press. In addition, she consults with sports leagues via her university affiliation. Dr. Postolache reports financial support from the VA, NIH, the state of Maryland, and the DC Department of Behavioral Health. Dr. Lowry reports grants from the NIH, NSF, and VA. In addition, Dr. Lowry serves on the Scientific Advisory Board of Immodulon Therapeutics, Ltd., is Cofounder, Board Member, and Chief Scientific Officer of Mycobacteria Therapeutics Corporation, and is a member of the faculty of the Integrative Psychiatry Institute, Boulder, Colorado. The remaining authors declare that the research was conducted in the absence of any relevant commercial or financial relationships that could be construed as a potential conflict of interest.